₹ 464.10
20.45 (4.61%)
C
Cohance Lifesciences
₹ 464.10
Cohance Lifesciences Fundamentals
Company Valuation
Market Cap (₹ Cr.)
17,756
PE Ratio
-2,955.70
PB Ratio
4.34
Dividend Yield
1.35%
ROE
3.72%
ROCE
4.81%
Book Value (₹)
102.25
Face Value (₹)
1.00
Analyse COHANCE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 57.49% | 57.49% | 57.49% | 57.49% | 57.48% |
| Domestic Institutional Investors (DII) | 20.82% | 21.57% | 21.79% | 20.09% | 18.86% |
| Foreign Institutional Investors (FII) | 6.51% | 6.02% | 5.59% | 6.50% | 7.71% |
| Public Investors | 6.42% | 6.76% | 7.04% | 7.71% | 7.50% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
COHANCE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Smallcap
BSE Scrip Code
543064
NSE Scrip Name
COHANCE
ISIN
INE03QK01018
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






